TASTYLIA 80

What is TASTYLIA 80?

TASTYLIA 80 is a modern medication designed for the correction of erectile dysfunction in men, belonging to the pharmacological group of phosphodiesterase type 5 inhibitors. The drug is manufactured by Fortune Healthcare, a company specializing in creating innovative products to improve men's health. The main difference of TASTYLIA 80 lies in its dosage form — these are oral films that dissolve directly in the oral cavity without the need for water. This format provides rapid absorption of the active component through the mucous membrane, bypassing the initial pass through the liver. Thanks to this, the therapeutic effect occurs significantly faster compared to traditional tablet forms.

The active ingredient of the drug is tadalafil at a dosage of 80 mg, which provides a pronounced and long-lasting action for at least 36 hours. Tadalafil selectively blocks the phosphodiesterase type 5 enzyme, which is responsible for the breakdown of cyclic guanosine monophosphate in the cavernous bodies of the penis. The accumulation of this substance leads to the relaxation of vascular smooth muscle and increased blood filling, which ensures a stable erection during sexual stimulation. It is important to understand that the drug does not cause an erection without natural arousal, but only enhances the physiological response to sexual stimuli. Such a mechanism of action is as close as possible to the body's natural processes.

TASTYLIA 80 is positioned as a product for men who need a reliable solution to potency problems and wish to obtain maximum freedom in planning their intimate life. Oral films have a pleasant taste, making the intake of the drug comfortable and discreet for others. The product has passed the necessary clinical studies confirming its bioequivalence to the original tadalafil preparations. The manufacturer Fortune Healthcare guarantees the high quality of each unit of production thanks to strict control at all stages of manufacturing. The drug is dispensed by prescription, as it requires a preliminary assessment of the patient's cardiovascular system condition.

What is TASTYLIA 80 prescribed for?

The main indication for the use of TASTYLIA 80 is erectile dysfunction of various origins, manifested by the inability to achieve or maintain an erection sufficient for satisfactory sexual intercourse. The drug is effective both for psychogenic forms of the disorder associated with stress, anxiety, or depressive states, and for organic causes stemming from vascular, neurological, or hormonal changes. Tadalafil as part of TASTYLIA 80 helps restore the natural vascular response to sexual arousal, which is especially important for men over 40 years old. Clinical experience shows that the drug demonstrates high efficacy even in patients with chronic diseases such as diabetes mellitus or arterial hypertension. However, it is important to note that TASTYLIA 80 is not a hormonal agent and does not affect libido or testosterone levels.

The second important indication is the symptomatic treatment of benign prostatic hyperplasia, accompanied by urination disorders, frequent nocturnal urges, and a feeling of incomplete bladder emptying. Tadalafil relaxes the smooth muscle not only of the penile blood vessels, but also of the prostate tissues and bladder neck, which helps improve urodynamics. Such a dual effect makes TASTYLIA 80 particularly valuable for men in whom erectile dysfunction is combined with age-related changes of the prostate gland. The drug allows for the simultaneous resolution of both problems without the need to take multiple medications. This significantly increases patient compliance and reduces the risk of polypharmacy.

TASTYLIA 80 may also be recommended for men who are recovering after radical prostatectomy or radiation therapy for prostate cancer, as the drug promotes the rehabilitation of erectile function. In such cases, the use of phosphodiesterase type 5 inhibitors is considered as part of a comprehensive recovery program. Importantly, the decision to prescribe the drug in such clinical situations is made exclusively by a doctor after a thorough assessment of the patient's oncological status. Self-medication in such cases is categorically unacceptable, as it can mask the symptoms of underlying disease progression. The drug is not intended for use by women or individuals under 18 years of age.

Composition and active components of TASTYLIA 80

The main active component of TASTYLIA 80 is tadalafil at a concentration of 80 mg per single oral film. Tadalafil belongs to selective phosphodiesterase type 5 inhibitors, which act directly on enzymatic processes in the cavernous bodies of the penis. The mechanism of action consists in blocking the cleavage of cyclic guanosine monophosphate, which leads to the accumulation of this signaling molecule in vascular smooth muscle cells. The increased concentration of cyclic guanosine monophosphate activates protein kinase G, which triggers a cascade of reactions ending in the relaxation of the vascular wall and an increased inflow of arterial blood. This process occurs only under the condition of sexual stimulation, which ensures the physiological nature of the erection.

Excipients of TASTYLIA 80 oral films include polymers that form a matrix for the uniform distribution of the active substance, plasticizers that provide flexibility and elasticity to the film, as well as flavor correctors for pleasant perception. The composition of excipients is selected in such a way as to ensure rapid release of tadalafil upon contact with saliva and the mucous membrane of the oral cavity. The manufacturing technology involves the use of hydrophilic polymers that completely dissolve within one to two minutes, leaving no foreign body sensation. The manufacturer Fortune Healthcare uses only certified raw materials that meet international quality standards.

A feature of the pharmacokinetics of TASTYLIA 80 is the absorption of tadalafil through the oral mucosa, which avoids the first-pass effect through the liver. This provides faster achievement of therapeutic concentration in blood plasma compared to oral tablets. The elimination half-life of tadalafil averages 17.5 hours, providing a long therapeutic effect of up to 36 hours. Such a pharmacokinetic characteristic allows the patient not to tie the intake of the drug to a specific moment of intimacy. This significantly reduces psychological pressure and promotes more natural sexual behavior.

Dosage of TASTYLIA 80

The standard recommended dose of TASTYLIA 80 for adult men is one 80 mg oral film as needed, approximately 30–60 minutes prior to expected sexual activity. The drug can be taken regardless of food intake, since absorption through the oral mucosa minimally depends on stomach fullness. The maximum recommended dosing frequency is no more than once a day, as the long elimination half-life of tadalafil creates a risk of drug accumulation in the body. Exceeding the specified dose does not lead to an enhancement of the therapeutic effect, but significantly increases the likelihood of side effects. Patients with impaired renal or hepatic function may require dose adjustment, which is determined individually by a doctor.

For men planning regular sexual activity, a doctor may recommend daily administration of lower doses of tadalafil; however, TASTYLIA 80 in the 80 mg format is not intended for daily use. In such cases, it is advisable to consider other dosage forms with lower dosages that allow maintaining a constant therapeutic concentration in blood plasma. The decision to switch to a daily regimen is made exclusively by a doctor after evaluating the efficacy and tolerability of the drug. Unapproved increase in the frequency of taking TASTYLIA 80 can lead to overdose and serious side effects from the cardiovascular system. The duration of the treatment course is determined individually depending on the cause of erectile dysfunction and the response to therapy.

Elderly patients over 65 years of age usually do not require dose adjustment for TASTYLIA 80, but due to increased sensitivity to the drug, it is recommended to start treatment with the minimum effective dose. For men with severe renal impairment or end-stage hepatic insufficiency, the use of the drug is contraindicated. When co-administered with CYP3A4 inhibitors, such as ketoconazole or ritonavir, the dose of TASTYLIA 80 should be reduced due to the slowing down of tadalafil metabolism. It is important to inform the doctor about all medications the patient is taking to avoid dangerous interactions.

How to take TASTYLIA 80 correctly?

The TASTYLIA 80 oral film should be removed from the individual packaging immediately before use and placed on the tongue, where it will begin to dissolve under the action of saliva. The film does not need to be chewed or swallowed with water, as this may disrupt the uniformity of absorption of the active component. It is recommended to hold the film in the oral cavity until completely dissolved, which usually takes from one to three minutes. After the drug dissolves, it is advisable to refrain from taking food and drinks for the next 10–15 minutes to ensure maximum contact of tadalafil with the mucous membrane. The drug can be taken regardless of the time of day, but for convenience, most patients choose the evening time.

If a scheduled dose of TASTYLIA 80 is missed, do not double the next dose, as this increases the risk of side effects without improving the therapeutic result. If the drug is used as needed, a missed dose is of no clinical significance, as the next dose can be taken at a convenient time. It is important to remember that TASTYLIA 80 acts only in the presence of sexual stimulation, so expecting a spontaneous erection without appropriate arousal is a mistake. The drug does not protect against sexually transmitted infections, so barrier methods of contraception should be used during casual sexual contact. Before starting the use of TASTYLIA 80, it is necessary to undergo an examination to rule out cardiovascular contraindications.

TASTYLIA 80 oral films should be stored in the original packaging at a temperature not exceeding 25 degrees Celsius in a dry place protected from direct sunlight. Do not use the drug after the expiration date or if the integrity of the individual packaging is violated. If the film becomes brittle, changes color, or sticks together, this indicates a violation of storage conditions, and such a drug should not be used. Patients with sensitivity to the components of the drug should carefully read the full composition before the first use. If any unusual reactions occur, it is necessary to stop taking it and seek medical advice.

Side effects of TASTYLIA 80

The most common side effects of TASTYLIA 80 are headache, facial flushing, nasal congestion, and dyspeptic disorders. These symptoms are caused by the systemic vasodilating action of tadalafil and are usually mild or moderate in nature. Headache occurs due to the dilation of cerebral vessels and is most often observed during the first hours after taking the drug. Hot flashes and facial redness are associated with increased peripheral circulation and usually resolve on their own within a few hours. Nasal congestion is explained by swelling of the nasal mucosa due to vasodilation and does not require special treatment.

Less common adverse reactions include back pain, muscle aches, dizziness, and visual disturbances. Back and muscle pain usually occurs 12–24 hours after taking tadalafil and is associated with the effect on skeletal muscles, resolving spontaneously within 48 hours. Visual disturbances may manifest as changes in color perception, increased sensitivity to light, or blurred vision, caused by the effect on phosphodiesterase type six in the retina. Rare but serious side effects are priapism — a prolonged erection lasting more than four hours, and sudden loss of vision or hearing. If priapism occurs, immediate medical attention is required, as prolonged ischemia of the cavernous bodies can lead to irreversible tissue damage.

The body's individual response to TASTYLIA 80 can vary significantly depending on age, health status, concomitant diseases, and simultaneous intake of other medications. Patients should carefully monitor their well-being after the first dose of the drug and report any unusual symptoms to their doctor. If side effects persist for more than 48 hours or are severe, it is necessary to stop using the drug and seek medical help. A doctor may adjust the dose or recommend an alternative drug with a better tolerability profile for a specific patient.

Contraindications of TASTYLIA 80

An absolute contraindication to the use of TASTYLIA 80 is the concomitant use of nitrates or nitric oxide donors in any dosage forms, as the combination of these drugs leads to a critical drop in blood pressure. This applies to nitroglycerin, isosorbide dinitrate, isosorbide mononitrate, and other nitrate drugs used to treat angina. Patients taking nitrates must strictly refrain from using TASTYLIA 80, as the risk of developing life-threatening hypotension is extremely high. The drug is also contraindicated in men with hypersensitivity to tadalafil or any excipient of the oral films. A history of allergic reactions to other phosphodiesterase type 5 inhibitors is also a contraindication.

TASTYLIA 80 should not be used in patients with severe cardiovascular diseases, including recent myocardial infarction or stroke within the last six months, unstable angina, heart failure of second or higher functional class according to the New York Heart Association classification. The drug is contraindicated in severe arterial hypotension with blood pressure below 90/50 mmHg and in uncontrolled arterial hypertension. In men with conditions predisposing to priapism, such as sickle cell anemia, multiple myeloma, or leukemia, the use of the drug is possible only after a careful assessment of the benefit-risk ratio. Severe hepatic impairment and end-stage renal disease are also contraindications.

TASTYLIA 80 is not intended for use by women, children, and adolescents under 18 years of age. Pregnancy and lactation are absolute contraindications, as safety studies of tadalafil in these groups have not been conducted. For men with anatomical deformations of the penis, such as Peyronie's disease, angiofibroma, or cavernosal fibrosis, the drug should be prescribed with caution due to an increased risk of priapism. Patients with retinitis pigmentosa or other hereditary retinal diseases require consultation with an ophthalmologist before starting therapy. Before using TASTYLIA 80, a doctor's consultation is mandatory to exclude contraindications and assess overall health status.

Interaction of TASTYLIA 80 with other drugs and alcohol

The most dangerous drug interaction of TASTYLIA 80 is the combination with nitrates and nitric oxide donors, which leads to a sharp drop in blood pressure, loss of consciousness, and even fatal outcomes. Concomitant administration with alpha-blockers used to treat prostate hyperplasia or arterial hypertension can cause orthostatic hypotension, so such a combination requires careful medical supervision. CYP3A4 inhibitors, including ketoconazole, itraconazole, ritonavir, erythromycin, and clarithromycin, slow down tadalafil metabolism, leading to an increase in its concentration in the blood and increased side effects. CYP3A4 inducers, such as rifampicin, carbamazepine, or phenytoin, on the contrary, accelerate the elimination of the drug and reduce its efficacy. Grapefruit juice can also affect tadalafil metabolism, so its consumption should be limited during therapy.

Alcohol consumption while using TASTYLIA 80 is not absolutely contraindicated, but moderation should be exercised, as excessive amounts of alcohol enhance the vasodilating effect of the drug. Combining tadalafil with large amounts of alcohol increases the risk of orthostatic hypotension, dizziness, and headache. In addition, alcohol itself can impair erectile function, which negates the therapeutic effect of the drug. Patients planning to consume alcohol are recommended to limit themselves to minimal doses and avoid combining it with taking TASTYLIA 80 in the coming hours. The effect of the drug on the ability to drive vehicles is insignificant, but if dizziness or visual disturbances occur, one should refrain from driving until symptoms completely disappear.

Where to buy TASTYLIA 80 in Ukraine

TASTYLIA 80 is available for purchase in licensed pharmacy establishments in Ukraine by prescription, which guarantees the authenticity of the product and compliance with storage conditions. The drug can also be ordered through official online platforms of pharmacy chains that deliver throughout the country. When buying, it is important to pay attention to the integrity of the packaging, the presence of protective elements, and the compliance of the batch number with the data of the manufacturer Fortune Healthcare. Oral films should be stored at room temperature in the original packaging, avoiding exposure to moisture and direct sunlight. The shelf life of the drug is usually 24 months from the date of manufacture, and use after its expiration is strictly prohibited.

Before purchasing TASTYLIA 80, it is mandatory to consult a doctor to obtain a prescription and rule out contraindications, as self-medication of erectile dysfunction can be dangerous. The doctor will conduct the necessary examination, determine the cause of the disorder, and select the optimal therapy regimen. Patients should remember that erectile dysfunction can be an early symptom of serious cardiovascular diseases, so timely diagnosis is critically important. The body's individual response to the drug may vary, so the first dose is recommended to be taken in a calm setting with the ability to monitor one's well-being. If any doubts arise regarding the efficacy or safety of the drug, you should consult a qualified medical professional.